UNITED LAB3933.HKValuation Analysis
Based on the blended 10-year P/E and P/B percentiles, the stock currently sits in the “Fair Value Range” zone.
As of Oct 16, 2026, UNITED LAB (3933.HK) trades at a P/E of 22.10x, P/B of 0.72x, P/S of 1.05x, and a dividend yield of 4.12%.
Longitudinal percentile comparison: P/E sits at the 85th percentile over the trailing 10Y window (vs. 96th percentile over 3Y); P/B sits at the 8th percentile over the trailing 10Y window (vs. 1st percentile over 3Y); P/S sits at the 47th percentile over the trailing 10Y window (vs. 21st percentile over 3Y).
Cross-sectional valuation: its P/E ranks at the 79th percentile within its industry and the 76th percentile across the broader market.
Shareholder return highlight: Total Shareholder Yield is 4.28%, ranking at the 71st percentile over the trailing 20Y window.
Notably, P/E and P/B aren't telling quite the same story, 77.1 points apart — worth checking the full percentile matrix on this page for the complete picture. Its P/E percentile is roughly the same whether measured against the industry or the broader market. Shareholder returns here are driven almost entirely by cash dividends, with minimal contribution from buybacks. UNITED LAB operates in the Pharmaceutical Chemistry sector. Data refreshes weekly and is for reference only, not investment advice.
Also listed as: HKG: 3933 · SEHK: 3933 · 3933
Want the full picture on whether UNITED LAB (3933.HK) is under- or over-valued? See the full 3Y / 5Y / 10Y / 20Y P/E, P/B, P/S, Dividend Yield & Total Shareholder Yield percentile matrix and the interactive ECharts trend chart on this page.
Historical Percentiles by Metric
| Metric | Current | Market Percentile | Industry Percentile | 3Y Pctl | 5Y Pctl | 10Y Pctl | 20Y Pctl |
|---|---|---|---|---|---|---|---|
| P/E (TTM) | 22.10 | ||||||
| P/B (MRQ) | 0.72 | ||||||
| P/S (TTM) | 1.05 | ||||||
| Dividend Yield | 4.12% | ||||||
| Buyback + Div Yield | 4.28% |